{"DataElement":{"publicId":"6118560","version":"1","preferredName":"Malignant Neoplasm Sum Target Lesion Present Count","preferredDefinition":"A response used to determine the final aggregate number of tumors composed of atypical neoplastic, often pleomorphic cells that invade other tissues that are the primary target of the therapeutic intervention.","longName":"6118357v1.0:2018392v1.0","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"6118357","version":"1","preferredName":"Malignant Neoplasm Sum Target Lesion Present","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._The final aggregate amount._An object fixed as a goal or point of examination; something to point at; a destination._A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._Being or existing in a specified place or at the specified time.","longName":"2186369v1.0:6118355v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"2186369","version":"1","preferredName":"Malignant Neoplasm","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A888-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6118355","version":"1","preferredName":"Sum Target Lesion Present","preferredDefinition":"The final aggregate amount.:An object fixed as a goal or point of examination; something to point at; a destination.:A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.:Being or existing in a specified place or at the specified time.","longName":"C25697:C25702:C3824:C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sum","conceptCode":"C25697","definition":"The final aggregate amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Target","conceptCode":"C25702","definition":"An object fixed as a goal or point of examination; something to point at; a destination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66FA82FA-0CC3-086F-E053-F662850A1524","latestVersionIndicator":"Yes","beginDate":"2018-03-09","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-09","modifiedBy":"ONEDATA","dateModified":"2018-03-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66FA82FA-0CD4-086F-E053-F662850A1524","latestVersionIndicator":"Yes","beginDate":"2018-03-09","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-09","modifiedBy":"GARRIDOJ","dateModified":"2018-07-11","changeDescription":"Created for EA5152, 03/09/18 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018392","version":"1","preferredName":"Count","preferredDefinition":"The quantity of the specified item.","longName":"CT","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":"1","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008541","version":"1","preferredName":"Numbers","preferredDefinition":"the set of non-negative integers.","longName":"NUMS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227CE66-2830-4A7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2261845","version":"1","preferredName":"Count","preferredDefinition":"To determine the number or amount of something; the result of this activity.","longName":"C25463","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Count","conceptCode":"C25463","definition":"Determining the number or amount of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FBB87F7A-646B-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-13","modifiedBy":"ONEDATA","dateModified":"2005-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B3BF4389-4489-5F2C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-09","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-01-08","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/11/17 tt transferred context, added reg status and CSI per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"11518160","version":"1","longName":"CTDC (Clinical Trial Data Commons)","context":"CRDC","ClassificationSchemeItems":[{"publicId":"13484613","version":"1","longName":"MATCHBox","context":"CRDC"},{"publicId":"13484614","version":"1","longName":"ECOG-ACRIN DD","context":"CRDC"}]},{"publicId":"3314482","version":"1","longName":"Type of Category","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"5936696","version":"1","longName":"Disease Assessment ","context":"ECOG-ACRIN"}]}],"AlternateNames":[{"name":"nlesb","type":"CTDC Alt Name","context":"CRDC"},{"name":"number_of_baseline_targeted_lesions","type":"CTDC Alt Name","context":"CRDC"}],"ReferenceDocuments":[{"name":"Total number of target lesions","type":"Preferred Question Text","description":"Total number of target lesions","url":null,"context":"ECOG-ACRIN"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66FA82FA-0CF4-086F-E053-F662850A1524","latestVersionIndicator":"Yes","beginDate":"2018-03-09","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-03-09","modifiedBy":"SOKKERL","dateModified":"2023-07-05","changeDescription":"Created for EA5152, 03/09/18 JG","administrativeNotes":"5/4/23 :classified and added CTDC ALTname for ECOG/DD. LS","unresolvedIssues":null,"deletedIndicator":"No"}}